MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stillman, B. A.
Right arrow Articles by Breyer, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stillman, B. A.
Right arrow Articles by Breyer, R. M.

Vol. 56, Issue 3, 545-551, September 1999

Importance of the Extracellular Domain for Prostaglandin EP2 Receptor Function

Brett A. Stillman, Matthew D. Breyer, and Richard M. Breyer

Division of Nephrology, Department of Pharmacology and Vanderbilt Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee

The ligand binding pocket of biogenic amine G protein-coupled receptors is embedded in the membrane-spanning regions of these receptors, whereas the extracellular domains of the peptidergic receptors play a key role in the structure and function of this class of receptors. To examine the role of the extracellular sequences in prostaglandin receptor-ligand interaction, chimeras were constructed with the two Gs-coupled E-prostanoid (EP) receptors, replacing each of the extracellular sequences of the human EP2 receptor with the corresponding human EP4 receptor residues. Replacement of the third extracellular loop (ECIII) yielded a receptor that binds [3H]prostaglandin E2 (PGE2; Kd = 6.3 nM) with similar affinity as the EP2 wild-type receptor (Kd = 12.9 nM). Similarly, replacement of the nonconserved carboxyl-terminal portion of ECII resulted in a receptor that maintains [3H]PGE2 binding (Kd = 8.8 nM). In contrast, replacement of the amino terminus, ECI, the entire ECII region, or the residues within the highly conserved motif of the amino-terminal half of ECII yielded chimeras that displayed neither detectable [3H]PGE2 binding nor receptor-evoked cAMP generation. Immunoprecipitation demonstrated that each chimera is expressed at levels near that of wild-type receptors; however, enzyme-linked immunosorbent assay revealed that inactive chimeras have reduced cell surface expression. Similarly, chimeras that exchange the multiple extracellular loop sequences N/ECI, ECII/ECIII, or all four sequences lacked detectable binding and signal transduction, and although expressed, were not detected on the cell surface. These data suggest that the extracellular sequences of the EP2 receptor are critical determinants of receptor structure and/or function, unlike other G protein-coupled receptors that bind small molecules.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Circ. Res.Home page
R. Li, K. P. Mouillesseaux, D. Montoya, D. Cruz, N. Gharavi, M. Dun, L. Koroniak, and J. A. Berliner
Identification of Prostaglandin E2 Receptor Subtype 2 As a Receptor Activated by OxPAPC
Circ. Res., March 17, 2006; 98(5): 642 - 650.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. L. Konger, G. A. Scott, Y. Landt, J. H. Ladenson, and A. P. Pentland
Loss of the EP2 Prostaglandin E2 Receptor in Immortalized Human Keratinocytes Results in Increased Invasiveness and Decreased Paxillin Expression
Am. J. Pathol., December 1, 2002; 161(6): 2065 - 2078.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Akal-Strader, S. Khare, D. Xu, F. Naider, and J. M. Becker
Residues in the First Extracellular Loop of a G Protein-coupled Receptor Play a Role in Signal Transduction
J. Biol. Chem., August 16, 2002; 277(34): 30581 - 30590.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Baillie, S. J. MacKenzie, and M. D. Houslay
Phorbol 12-myristate 13-acetate Triggers the Protein Kinase A-Mediated Phosphorylation and Activation of the PDE4D5 cAMP Phosphodiesterase in Human Aortic Smooth Muscle Cells through a Route Involving Extracellular Signal Regulated Kinase (ERK)
Mol. Pharmacol., November 1, 2001; 60(5): 1100 - 1111.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. D. Breyer and R. M. Breyer
Prostaglandin E receptors and the kidney
Am J Physiol Renal Physiol, July 1, 2000; 279(1): F12 - F23.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics